October 30, 2026

FDA approves tildrakizumab for psoriatic arthritis

The IL-23 inhibitor gains a new indication after 2 phase 3 trials show improved joint responses versus placebo.

MDSpire News

October 30, 2026

Monthly fasting cycles may be feasible in T2D

Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate.

MDSpire News

October 30, 2026

High TIRADS may signal cancer despite benign cytology

Patients with higher ultrasound risk classifications had about 5.7 times the adjusted odds of postoperative malignancy in a selected surgical cohort.

MDSpire News

October 30, 2026

Pedicle freezing may aid distal femur salvage

Investigators reported 90% limb preservation without nonunion, although graft resorption complicated reconstruction in skeletally immature patients.

MDSpire News

October 29, 2026

FDA, CMS target gene therapy barriers

FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.

MDSpire News

October 29, 2026

Why Better Care Needs Better Connections

Improving the flow of diagnostic information across care teams can save money, reduce delays, and support better patient outcomes

The Pathologist

October 29, 2026

Digoxin misses heart failure endpoint

Researchers observed fewer worsening heart failure events, but the trial did not establish a statistically significant benefit.

MDSpire News

October 29, 2026

Surface EMG may restore speech after laryngectomy

Investigators converted silently articulated words into intelligible speech and recreated a patient's presurgical voice.

MDSpire News

October 29, 2026

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

MDSpire News

October 29, 2026

CDC mandates Ebola attestation for US-bound flights

The new requirement applies to US citizens, permanent residents, and foreign travelers.

MDSpire News